Abzena

Abzena, a San Diego CDMO, secured a $65 million investment to expand its drug substance and fill-finish manufacturing capacity, including building out in North Carolina.

Abzena announced it will be acquired by Astro Bidco, a wholly-owned subsidiary of Welsh, Carson, Anderson & Stowe (WCAS), for approximately £34.4 million ($43.7 million). Shareholders will receive 16p per share, a 167% premium over the trading price.

Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and GMP manufacturing services for an antibody-drug conjugate (ADC) valued at over $5 million. Services will be carried out in Bristol, PA and San Diego, CA.